{"slug":"tb-500-muscle-loss","verification":{"valid":true,"entries":2,"head":"6221e6daa5a3f9ed199e7335eb65b8aad6755779d964ed66d7b87f1943c2aba5"},"energy":{"passes":2,"tokens_in":18046,"tokens_out":3378,"tokens_total":21424,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"6221e6daa5a3f9ed199e7335eb65b8aad6755779d964ed66d7b87f1943c2aba5"},"provenance":[{"ts":"2026-06-29T23:36:09.742Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Muscle Loss\nSlug: tb-500-muscle-loss\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_","response":"{\"slug\":\"tb-500-muscle-loss\",\"title\":\"TB-500 for Muscle Loss: What the Data Shows on Repair Pathways\",\"body\":\"## What's breaking down\\n\\nMuscle loss, whether from disuse, aging, injury, or disease, occurs when breakdown outruns repair. Satellite cells fail to activate and migrate effectively. Inflammation lingers instead of clearing. Actin cytoskeleton organization disrupts, limiting cell movement and tissue rebuilding. Blood vessel formation slows, starving repair sites of nutrients. In these layers, degeneration dominates because repair cells cannot reach damage zones fast enough or organize new structure.\\n\\nTB-500 is studied as a fragment of thymosin beta-4. The focus stays on whether it targets those specific repair failures rather than suppressing symptoms.\\n\\n## Why TB-500 might help you\\n\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\nIf muscle loss stems from poor cell migration after strain or atrophy, the logic chain points to TB-500's actin regulation as one studied mechanism. This differs from drugs that only reduce load or inflammation without addressing migration.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **TB-500** → inflammation clearance / repair-cell migration\\n\\n## What the evidence actually shows\\n\\nHuman data remains scarce and indirect. Phase 1 safety studies in healthy volunteers reported good tolerability with no dose-limiting toxicities (source s1). Phase 2 trials examined thymosin beta-4 for dry eye and certain wounds, sho","tokens_in":18046,"tokens_out":3378,"cost":0,"prev":"genesis","hash":"36780fc230bbb9d224e24d5ce9a570e2bcd9ac45c482b319dfe9aaab824b383b"},{"ts":"2026-07-17T02:42:16.392Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-muscle-loss","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"36780fc230bbb9d224e24d5ce9a570e2bcd9ac45c482b319dfe9aaab824b383b","hash":"6221e6daa5a3f9ed199e7335eb65b8aad6755779d964ed66d7b87f1943c2aba5"}]}